X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (219) 219
Publication (35) 35
Book / eBook (13) 13
Conference Proceeding (12) 12
Newspaper Article (12) 12
Book Review (11) 11
Magazine Article (5) 5
Dissertation (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (123) 123
humans (106) 106
male (75) 75
aged (57) 57
female (51) 51
alzheimer's disease (41) 41
dementia (37) 37
oncology (37) 37
alzheimer disease - genetics (36) 36
genetic aspects (35) 35
middle aged (35) 35
article (33) 33
clinical neurology (33) 33
neurosciences (33) 33
research (33) 33
risk factors (33) 33
aged, 80 and over (29) 29
abridged index medicus (28) 28
analysis (26) 26
genome-wide association study (25) 25
prostate cancer (25) 25
risk (25) 25
genetic predisposition to disease (24) 24
genetics (24) 24
neurology (24) 24
polymorphism, single nucleotide (24) 24
mutation (23) 23
genome-wide association (22) 22
genomics (21) 21
genotype (21) 21
care and treatment (20) 20
common variants (20) 20
genomes (20) 20
health aspects (20) 20
alzheimers disease (19) 19
case-control studies (19) 19
physiological aspects (18) 18
epidemiology (17) 17
frontotemporal dementia (16) 16
genes (16) 16
genetic research (16) 16
geriatrics & gerontology (16) 16
aging (15) 15
cancer (15) 15
cohort studies (15) 15
gene expression (15) 15
mutations (15) 15
pathology (15) 15
association (14) 14
brain (14) 14
adult (13) 13
age of onset (13) 13
genetics & heredity (13) 13
identifies variants (13) 13
medicine & public health (13) 13
meta-analysis (13) 13
metaanalysis (13) 13
neurodegenerative diseases (13) 13
clinical trials (12) 12
consortia (12) 12
genetic variation (12) 12
medical research (12) 12
multidisciplinary sciences (12) 12
studies (12) 12
clinical medicine (11) 11
enzalutamide (11) 11
loci (11) 11
medical and health sciences (11) 11
medicin och hälsovetenskap (11) 11
men (11) 11
amyotrophic-lateral-sclerosis (10) 10
diagnosis (10) 10
disease (10) 10
gene (10) 10
internal medicine (10) 10
klinisk medicin (10) 10
polymorphism, single nucleotide - genetics (10) 10
single nucleotide polymorphisms (10) 10
treatment outcome (10) 10
androgens (9) 9
animals (9) 9
development and progression (9) 9
docetaxel (9) 9
frontotemporal lobar degeneration (9) 9
genetic predisposition to disease - genetics (9) 9
metastasis (9) 9
patients (9) 9
prostatic neoplasms, castration-resistant - drug therapy (9) 9
proteins (9) 9
quality of life (9) 9
therapy (9) 9
alzheimers-disease (8) 8
chemotherapy (8) 8
exercise (8) 8
linkage disequilibrium (8) 8
magnetic resonance imaging (8) 8
medicine (8) 8
medicine, general & internal (8) 8
mental disorders (8) 8
neoplasm metastasis (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Music - Closed Orders (1) 1
Music - Reference (1) 1
New College (Ivey) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 09/2013, Volume 119, Issue 18, pp. 3262 - 3264
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2018, Volume 378, Issue 15, pp. 1408 - 1418
Among men with nonmetastatic prostate cancer who had a rapid PSA doubling time and were receiving androgen-deprivation therapy, the median metastasis-free... 
MEDICINE, GENERAL & INTERNAL | THERAPY | LIGANDS | BONE METASTASES | MEN | ARN-509 | ANTIGEN | Prostate-Specific Antigen | Double-Blind Method | Humans | Middle Aged | Proportional Hazards Models | Male | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms, Castration-Resistant - pathology | Disease-Free Survival | Thiohydantoins - adverse effects | Exanthema - chemically induced | Neoplasm Metastasis - prevention & control | Thiohydantoins - therapeutic use | Aged, 80 and over | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Prostate cancer | Care and treatment | Metastasis | Medical research | Antigens | Lymphatic system | Medical imaging | Prostate-specific antigen | Research & development--R&D | Family medical history | Hypothyroidism | Survival | Patients | Metastases | Androgens | Hospitals | Castration | Prostate | Index Medicus | Abridged Index Medicus | Adenocarcinoma | pathology | Androgen Antagonists | Exanthema | 80 and over | Prostatic Neoplasms | Neoplasm Metastasis | Thiohydantoins | Urologi och njurmedicin | drug therapy | chemically induced | Castration-Resistant | prevention & control | secondary | adverse effects | Urology and Nephrology | therapeutic use
Journal Article
Oncotarget, ISSN 1949-2553, 08/2016, Volume 7, Issue 33, pp. 52810 - 52817
While programmed cell death 1 (PD-1) inhibitors have shown clear anti-tumor efficacy in several solid tumors, prior results in men with metastatic castration... 
Immune response | Immunotherapy | Immunology and Microbiology Section | Enzalutamide | Immunity | PD-1 | Prostate cancer | DOCETAXEL | INFILTRATION | CELL BIOLOGY | CELL LUNG-CANCER | prostate cancer | PEMBROLIZUMAB | MELANOMA | immunotherapy | PD-L1 | NIVOLUMAB | enzalutamide | IPILIMUMAB | ANTIGEN | Phenylthiohydantoin - adverse effects | Hypothyroidism - chemically induced | Humans | Middle Aged | Prostatic Neoplasms, Castration-Resistant - immunology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Myositis - chemically induced | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hypothyroidism - immunology | Myositis - immunology | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Aged, 80 and over | Prostatic Neoplasms, Castration-Resistant - prevention & control | Prostate-Specific Antigen - metabolism | Antibodies, Monoclonal, Humanized - adverse effects | Phenylthiohydantoin - immunology | Drug Administration Schedule | Programmed Cell Death 1 Receptor - metabolism | Antineoplastic Combined Chemotherapy Protocols - immunology | Prostatic Neoplasms, Castration-Resistant - metabolism | Remission Induction | Phenylthiohydantoin - analogs & derivatives | Phenylthiohydantoin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Prostate-Specific Antigen - immunology | Antibodies, Monoclonal, Humanized - immunology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Investigational New Drugs, ISSN 0167-6997, 4/2015, Volume 33, Issue 2, pp. 480 - 489
Journal Article
Cancer, ISSN 0008-543X, 09/2013, Volume 119, Issue 18, pp. 3262 - 3264
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 09/2015, Volume 15, Issue 9, pp. 977 - 979
Journal Article